| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $194.9M | — | +29.0% |
| Cost of Revenue | $57.1M | — | +28.2% |
| Gross Profit | $137.9M | — | +29.3% |
| R&D Expense | $51.2M | — | +55.1% |
| SG&A Expense | $70.9M | — | +102.9% |
| Operating Income | -$79.2M | — | -307.2% |
| Pre-tax Income | -$221.9M | — | -504.5% |
| Income Tax | $3.5M | — | -33.0% |
| Net Income | -$225.4M | -483.6% | -438.2% |
| EPS (Basic) | -$4.58 | — | -397.8% |
| EPS (Diluted) | -$4.58 | — | -397.8% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $809.1M | — | — |
| Accounts Receivable | $220.0M | — | — |
| Current Assets | $1.38B | — | — |
| Total Assets | $1.79B | — | — |
| Current Liabilities | $307.1M | — | — |
| Long-term Debt | $206.6M | — | -66.6% |
| Line Item | 2025-10-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$1.3M | — | — |
| Capital Expenditures | $589K | — | — |
| Investing Cash Flow | -$49.5M | — | — |
| Financing Cash Flow | $630.6M | — | — |
| Free Cash Flow | -$1.9M | — | — |
| Total Liabilities | $573.8M | — | — |
| Stockholders' Equity | $1.22B | +200.9% | +206.4% |